|

MGC026 Dose for Expansion Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • MacroGenics1

Indications

  • Liver Disease1
  • Esophageal Squamous Cell Cancer (SCC)1
  • Castration-Resistant Prostatic Cancer1
  • Gastro-Esophageal Cancer1
  • Clear Cell Renal Cell Carcinoma1

Los Angeles, California1 trial

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.